Skadden is advising Revance Therapeutics, while Kirkland & Ellis and Lowenstein Sandler are advising Crown Laboratories on the deal. Crown Laboratories, Inc., a privately held, global...
Crown Laboratories’ $924 Million Merger with Revance Therapeutics
Quantum’s Midstream Partnership with Comstock
Kirkland & Ellis counseled Quantum Capital Solutions on the transaction. Quantum Capital Solutions (“QCS”), an affiliate of Quantum Capital Group announced the formation of a midstream partnership...